Advancements in Endometriosis Diagnosis with Dr. John McNaught

Send us a text

In this episode, we explore the complex and often frustrating journey many people face when receiving a diagnosis of endometriosis. Despite advancements in medical testing and imaging, it still takes an average of 8-10 years for patients to be diagnosed.

Dr. McNaught reviews the symptoms, signs, and challenges surrounding its diagnosis and the patient experience of those who do not have the typical signs and symptoms of endometriosis. He discusses his conversations with patients who have lived for years with unexplained infertility and why reviewing the patient’s experience with pelvic pain as a teenager, as well as family history with endometriosis, can aid in the discovery. 

While treatments for endometriosis symptoms are well known, research on the disease is more limited. In the past several years, the toolbox for treatment options has expanded significantly beyond traditional options, with new, less invasive, and time-consuming diagnostic advancements on the horizon. 

Receiving a diagnosis is often a validating experience for patients who have felt ignored or dismissed for years. This information allows them to explain their symptoms to schools and workplaces, making it easier to manage the impact of this invisible disease. 

Dr. McNaught highlights the need for better research, less invasive diagnostics, and more comprehensive care for those with endometriosis. Join us as we explore the evolving landscape of diagnosis and treatment, highlighting the challenges and breakthroughs in managing this complex condition. As frustrating as this disease can be, Dr. McNaught says the future is bright for patients.

More About our Guest Speaker

Dr John McNaught is a leading reproductive endocrinologist based in London, Ontario. He is the Medical Director of CReATe Fertility London – a Partner Clinic of CReATe Fertility Centre, Toronto – one of Canada’s largest IVF Centres and nationally acclaimed in reproductive medicine and ground-breaking research.

He specializes in treating women with PCOS, endometriosis, recurrent IVF failures, recurrent pregnancy losses and male infertility cases. He has expertise in individualized personal care, assisted conception, male infertility, pelvic ultrasound, embryo transfer and IUI.

Over the years he has helped thousands of single, heterosexual and LGBTQ+ patients build their families. Dr McNaught’s medical approach is refreshingly unique, personalized and backed with medical research – all aimed at providing individual patients with their best possible outcome. Dr. McNaught’s empathetic style focuses on counseling and he considers natural fertility therapy as an area of specialization.

He also participates and conducts numerous online sessions and webinars to educate patients of all types about their options with fertility treatments.

Most importantly, Dr. McNaught is passionate about his work. He treats each case with the care and respect it deserves, working tirelessly to help patients reach their ultimate goal: a healthy child.

Afynia Laboratori

First Response Canada

Afynia Laboratories, a Canadian biotechnology company, is pleased to announce the availability of EndomiR, the first validated diagnostic blood test for endometriosis. Afynia is currently offering EndomiR to Canadian fertility clinics for patients with unexplained infertility and/or symptoms suggestive of endometriosis. EndomiR shortens the diagnostic pathway by providing physicians with actionable data to inform safe and effective treatment options. 

This episode is sponsored by First Response Canada.